Serina Therapeutics Inc (SER)
undefined
undefined%
At close: undefined
4.72
-2.68%
After-hours Jan 06, 2025, 08:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 142.00K 500.00K 3.04M 54.00K 1.73M 1.40M 1.40M 1.67M
Cost of Revenue 171.00K 145.00K 150.00K 1.28M 998.50K 841.00K 685.00K 911.00K
Gross Profit -29.00K 355.00K 2.89M -1.23M 729.50K 555.00K 719.00K 755.00K
Operating Income -9.96M -2.27M -1.63M -10.41M -12.56M -10.45M -8.42M -12.74M
Interest Income n/a 1.76K 10.86K n/a 29.00K 116.00K n/a n/a
Pretax Income -14.81M -2.68M -1.26M -10.40M -12.24M -7.73M -6.64M -17.36M
Net Income -14.80M -2.68M -1.26M -10.87M -12.15M -7.50M -6.58M -15.49M
Selling & General & Admin 9.33M 1.29M 1.30M 5.60M 7.94M 5.65M 3.87M 5.62M
Research & Development 603.00K 1.57M 3.80M 3.58M 5.35M 5.35M 5.27M 7.87M
Other Expenses n/a -265.92K n/a n/a n/a n/a n/a n/a
Operating Expenses 9.93M 2.77M 4.67M 9.18M 13.29M 11.00M 9.14M 13.49M
Interest Expense 4.90M 15.88K 3.09K 404.00K n/a n/a 12.00K 25.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 10.10M 2.77M 4.67M 10.46M 14.29M 11.84M 9.82M 14.40M
Income Tax -8.00K -250.04K 3.09K 466.00K 148.00K -229.00K -57.00K -1.86M
Shares Outstanding (Basic) 1.08M 1.08M 1.08M 1.07M 1.06M 992.72K 1.02M 1.02M
Shares Outstanding (Diluted) 1.08M 1.08M 1.08M 1.07M 1.06M 992.72K 1.02M 1.02M
EPS (Basic) -13.72 -2.49 -1.17 -10.14 -11.47 -7.56 -6.46 -15.21
EPS (Diluted) -13.72 -2.49 -1.17 -10.14 -11.47 -7.56 -6.46 -15.21
EBITDA -9.78M -2.60M -1.59M -8.74M -11.61M -7.20M -7.74M -11.89M
Depreciation & Amortization 131.00K 132.00K 131.00K 1.25M 951.00K 535.00K 682.00K 845.00K